E R McFadden. Show Affiliations »
Abstract
Entities: Disease
Mesh: See more » Acute DiseaseAdministration, InhalationAdrenergic beta-Agonists/administration & dosageAdrenergic beta-Agonists/therapeutic useAlbuterol/administration & dosageAlbuterol/therapeutic useAnti-Inflammatory Agents/administration & dosageAnti-Inflammatory Agents/pharmacologyAnti-Inflammatory Agents/therapeutic useAsthma/drug therapyBronchodilator Agents/administration & dosageBronchodilator Agents/therapeutic useFluocinolone Acetonide/administration & dosageFluocinolone Acetonide/analogs & derivativesFluocinolone Acetonide/pharmacologyFluocinolone Acetonide/therapeutic useForced Expiratory Volume/drug effectsGenes, MHC Class II/drug effectsGlucocorticoids/administration & dosageGlucocorticoids/pharmacologyGlucocorticoids/therapeutic useHumansMicrocirculation/drug effectsPeak Expiratory Flow Rate/drug effectsReceptors, Glucocorticoid/drug effectsTranscription, Genetic/drug effectsVasoconstrictor Agents/pharmacology
Substances: See more » Adrenergic beta-AgonistsAnti-Inflammatory AgentsBronchodilator AgentsGlucocorticoidsReceptors, GlucocorticoidVasoconstrictor AgentsFluocinolone AcetonideAlbuterolflunisolide
Year: 1998 PMID: 9517575 DOI: 10.1164/ajrccm.157.3.ed01-98
Source DB: PubMed Journal: Am J Respir Crit Care Med ISSN: 1073-449X Impact factor: 21.405